Keyphrases
Appropriate Dose
20%
Clinical Endpoints
20%
Combined Exposure
20%
Design Phase
20%
Dose Combination
20%
Dose Selection
20%
Dose-ranging Study
100%
Drug Combination
100%
Drug Effects
20%
Drug Interactions
20%
Exposure Analysis
100%
Exposure-response
100%
General Trends
20%
Interaction Model
40%
Interaction Parameter
20%
Mono-component
40%
Optimal Dose
20%
Parameter Estimation
40%
Pharmacodynamic Interactions
60%
Pharmacodynamics
20%
Phase II Trial
20%
Previous Knowledge
40%
Response Profiles
40%
Simulation Study
20%
Trial Size
20%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Drug
100%
Pharmacodynamic Parameter
33%
Pharmacodynamics
100%
Phase II Trials
33%